Meeting
2018 Cancer Survivorship Symposium
Risk prediction model for heart disease among endometrial cancer survivors.
Authors
Mia Hashibe
University of Utah School of Medicine, Salt Lake City, UT
Mia Hashibe , Brenna Blackburn , Jihye Park , Kerry G. Rowe , John Snyder , Yuan Wan , Vikrant Deshmukh , Michael Newman , Alison M Fraser , Ken R Smith , Kim Herget , Theresa Louise Werner , Veronica Wendy Setiawan , Nan Hu , Patricia A. Ganz , David K. Gaffney , Yuan-Chin Amy Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Chronic Anticancer Therapy; Late- and Long-term Effects/Comorbitidities; Psychosocial Issues; Risk Assessment
Track
Care Coordination, Cost, and Education,Late- and Long-term Effects/Comorbidities,Health Promotion,Psychosocial Issues,Communication and Transitions,Risk Assessment,Chronic Anti-Cancer Therapy
Sub Track
Long-term Complications/Sequelae of Treatment (Noncancer)
Citation
J Clin Oncol 36, 2018 (suppl 7S; abstr 120)
DOI
10.1200/JCO.2018.36.7_suppl.120
Abstract #
120
Poster Bd #
B11
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Lung cancer as a subsequent neoplasm: A report from the Childhood Cancer Survivor Study (CCSS).
First Author: Taumoha Ghosh
Poster
2017 ASCO Annual Meeting
Phase II study of cabozantinib (cabo) in patients (pts) with recurrent/metastatic endometrial cancer (EC): A study of the Princess Margaret, Chicago, and California phase II consortia.
First Author: Neesha C. Dhani
Poster
2014 ASCO Annual Meeting
Endometrial cancer survivors: What is their knowledge about obesity?
First Author: Leslie Horn Clark
Poster
2013 Breast Cancer Symposium
The impact treatment has on cardiovascular risks factors for breast cancer survivors.
First Author: John R. Keyserlingk